GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial

NCT06162715 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ENROLLING_BY_INVITATION

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Severe Obesity
Obesity
BMI Greater Than 30

Interventions

DRUG: Tirzepatide
OTHER: Standard of Care post-gastric bypass

Sponsor

Vanderbilt University Medical Center